ロード中...
Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients
The mutation status of the BRAF and NRAS genes in tumor tissue is used to select patients with metastatic melanoma for targeted therapy. Cell-free circulating DNA (cfDNA) represents an accessible, non-invasive surrogate sample that could provide a snapshot of the BRAF and NRAS genotype in these pati...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6281416/ https://ncbi.nlm.nih.gov/pubmed/30546839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26343 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|